InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Gentile Kimberly, Chief Operating Officer. Officer active across 2 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 6 reports have been published. Activity tracked since 25 November 2021. The latest transaction was filed on 5 January 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Gentile Kimberly is Director of Clinical Operations and SVP, Clinical Operations at Biohaven Ltd. and Biohaven Pharmaceutical Holding Co Ltd. She has 6 filings in total, and across the 6 recent filings observed between 2021-11-26 and 2026-01-07, sales total EUR 1760027, with the most frequent transaction nature listed as Option exercise.